Table 2 Peri-procedural morbidities of HCC patients who underwent SR or RFA.

From: A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices

 

SR, No. (%)

RFA, No. (%)

Overall morbidity

24 (35.3%)

16 (8.7%)

Major morbidity

6 (8.8%)

9 (4.9%)

Coronary artery disease

0 (0%)

0 (0%)

Cerebral vascular accident

0 (0%)

0 (0%)

Postoperative hemorrhage

0 (0%)

1 (0.5%)

Esophageal varices bleeding

1 (1.5%)

3 (1.6%)

Ascites

5 (7.4%)

2 (1.1%)

Hemothorax

3 (4.4%)

2 (1.1%)

Bile leakage

6 (8.8%)

0 (0%)

Infectious complications

6 (8.8%)*

2 (0.5%)**

Deterioration in liver function

11 (16.2%)

4 (2.2%)

Post-operative liver failure

2 (2.9%)

2 (1.1%)

Renal failure

0 (0%)

0 (0%)

Respiratory failure

1 (1.5%)

0 (0%)

Post-operative fever

23 (33.8%)

22 (12.0%)

  1. Major morbidity included post-operative liver failure, postoperative hemorrhage with hematoma formation, esophageal varices bleeding, abscess required drainage, bile leakage required drainage, and respiratory failure.
  2. HCC hepatocellular carcinoma; SR surgical resection; RFA radiofrequency ablation.
  3. *1 intrabdominal abscess, 1 urinary tract infection and 1 surgical site infection in the SR group.
  4. **1 intraabdominal abscess and 1 urinary tract infection in the RFA group.
Back to article page